Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Mar;12(1):6-7.
doi: 10.1159/000460238. Epub 2017 Feb 28.

Therapeutic Strategies in Triple-Negative Breast Cancer

Angelo Paradiso  1 , Christian F Singer  2
Affiliations
Editorial

Therapeutic Strategies in Triple-Negative Breast Cancer

Angelo Paradiso et al. Breast Care (Basel). 2017 Mar.
No abstract available

PubMed Disclaimer

References

    1. Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13:674–690. - PMC - PubMed
    1. Hubalek M, Czech T, Müller H. Biological subtypes of triple-negative breast cancer. Breast Care. 2017;12 DOI: 10.1159/000455820. - PMC - PubMed
    1. Hahnen E, Hauke J, Engel C, Neidhardt G, Rhiem K, Schmutzler R. Germline mutations in triple-negative breast cancer. Breast Care. 2017;12 DOI: 10.1159/ 000455999. - PMC - PubMed
    1. Kalimutho M, Parsons K, Mittal D, López JA, Srihari S, Khanna KK. Targeted therapies for triple-negative breast cancer: combating a stubborn disease. Trends Pharmacol Sci. 2015;36:822–846. - PubMed
    1. Andreopoulou E, Kelly CM, McDaid HM. Therapeutic advances and new directions for triple-negative breast cancer. Breast Care. 2017;12 DOI: 10.1159/000455821. - PMC - PubMed

Publication types